Endeavour's goal to double production with Terronera is expected to add $100-$150M in after-tax cash flow. Read why I upgrade ...

The deal amounted to HK$62.87m, or at HK$127.5 per share, same as previous close. BABA-W is now trading up 3.45% to HK$131.9, with 96.03 million shares of HK$12.68b ...

编者按：常染色体显性多囊肾病（ADPKD）作为导致慢性肾脏病（CKD）的重要单基因病因，在全球范围内，是引发肾脏替代治疗的常见病因之一。该疾病的肾功能预后与肾脏进展速率以及最终的囊性体积密切相关。临床一般使用来自身高调整的肾总体积（Ht-TKV）的线 ...

1,93,917-0.87% Volume: 1,30,182 Cr.